Stock listing
NIKA Stock Price, News, Filings & Events — Nika Pharmaceuticals Inc.
Selected listing: NIKA · OTC · USD · US
This page tracks Nika Pharmaceuticals Inc.'s NIKA:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NIKA:OTC. NIKA:OTC is the stock-level entry point for investors researching Nika Pharmaceuticals Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nika Pharmaceuticals Inc. is a public company traded under the ticker NIKA in the American market. With a market capitalization of approximately $806.3 million, the company is focused on developing and commercializing innovative pharmaceutical products. Nika Pharmaceuticals aims to address unmet medical needs through its research and development efforts.

- Ticker
- NIKA:OTC
- Asset type
- Stock
- Market cap
- $441.7M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- OTC
- Currency
- USD
Nika Pharmaceuticals Inc. NIKA:OTC stock context
This page tracks Nika Pharmaceuticals Inc.'s NIKA:OTC listing on OTC in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following NIKA:OTC. NIKA:OTC is the stock-level entry point for investors researching Nika Pharmaceuticals Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Nika Pharmaceuticals Inc. is a public company traded under the ticker NIKA in the American market. With a market capitalization of approximately $806.3 million, the company is focused on developing and commercializing innovative pharmaceutical products. Nika Pharmaceuticals aims to address unmet medical needs through its research and development efforts.
Latest news from Nika Pharmaceuticals Inc.
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) Funding Update
August 25, 2026
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) June 2026 Update
June 4, 2026
Nika Pharmaceuticals, Inc. (NIKA) Signed a Consultancy Agreement with MD Global Partners LLC
March 6, 2026
Nika Pharmaceuticals, Inc. (NIKA) Progress Update
December 3, 2025
UPDATE - Nika Pharmaceuticals, Inc. to Present at the Life Sciences Virtual Investor Forum June 11th-12th
June 12, 2025
Research Nika Pharmaceuticals Inc.
Nika Pharmaceuticals Inc. investor report
Review AI stock analysis and investor report context for NIKA:OTC.
Nika Pharmaceuticals Inc. company profile
View the public company page for Nika Pharmaceuticals Inc. on 6ix.
Nika Pharmaceuticals Inc. news
Read company news and market updates connected to Nika Pharmaceuticals Inc..
Nika Pharmaceuticals Inc. investor events
Find investor webinars, events, and replay context for Nika Pharmaceuticals Inc..